Tuesday's new era ... :-), page-2

You never know Blokes. We all know CYP has the potential. If the Germans and/or Japanese deal confirm, especially Apceth, as we know those brothers built a multi BILLION dollar company.

If they sign up, then for me, that's all the expertise I need to be convinced this is the real deal.
The doubts are out there due to, shall we say, over exuberant directors in 2015, lifting expectations of "commercial" deals. They got close, and they have advanced the company with Uni partnerships, no doubt. We are better off than a year ago, yet we took off at 41c. Better value now

Once/ if both convert, then we'll also be higher up on the big pharma radars, or those like Fuji, spending hundreds millions building a new division.

Some companies, you know are so safe and predictable that they won't make you "Rich" as you say, but this bio has all the ingredients.
One of the top multibag chances in 2016